Loading...
Bienvenue sur la collection HAL du laboratoire de BECCOH
Quelques conseils pour une publication "idéHALe"
• Pensez à respecter la signature institutionnelle
Université Paris-Saclay, UVSQ, BECCOH, 92104, Boulogne-Billancourt, France..
• Participez à l'accès ouvert
N'attendez pas : dès que votre article est en ligne, déposez dans Hal sa version acceptée pour publication et indiquez un embargo de 6 mois.
La loi pour une république numérique vous autorise en effet à partager cette version 6 mois après publications, quelque-soit l'éditeur
Plus d'informations Archives Ouverte : quid de mes droits d'auteurs ?
• Vous souhaitez disposer d'une page web référençant toutes vos publications ?
Créez vous en 5 minutes un idHal et un CVHAL
N'hésitez pas à nous contacter pour toutes questions,
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
Dernières Publications en accès ouvert dans Hal
-
Claire Gallois, Marine Sroussi, Thierry André, Sophie Mouillet-Richard, Natacha Agueeff, et al.. Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials. Journal of Clinical Oncology, 2025, ⟨10.1200/jco.23.02262⟩. ⟨hal-04955616⟩
-
-
-
-
-
Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie, et al.. Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer, 2024, 188, pp.107447. ⟨10.1016/j.lungcan.2023.107447⟩. ⟨hal-04517531⟩
-
Julie Lecuelle, Caroline Truntzer, Debora Basile, Luigi Laghi, Luana Greco, et al.. Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts. EBioMedicine, 2024, 105, pp.105207. ⟨10.1016/j.ebiom.2024.105207⟩. ⟨hal-04626841⟩
-
-
Johanne Seguin, Mostafa El Hajjam, Josette Legagneux, Sarah Diakhaby, Nathalie Mignet, et al.. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics, 2024, 16 (3), pp.315. ⟨10.3390/pharmaceutics16030315⟩. ⟨hal-04626840⟩
-
Robin Zagala, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbe, et al.. Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology, In press, ⟨10.1111/jdv.20155⟩. ⟨hal-04626767⟩
Mots clés
Acute generalized exanthematous pustulosis
Allelic imbalance
Colorectal cancer
Children
Plasma
Accommodations
Gastric bypass
Melanoma
AZD9291
Prognosis
Oncology
Survival
Mesenchymal stromal cells
Anti-PD1
Non-small cell lung cancer
Surgical excision
Immunothérapie
Thrombosis
Radiotherapy
ADN tumoral circulant
Circulating tumor DNA
Targeted therapy
Langerhans cell histiocytosis
Immunomodulation
BRAFV600E mutation
Wnt
Cutaneous squamous cell carcinoma
Abscopal effect anti-PD-1 antibody melanoma nivolumab pembrolizumab radiotherapy
Molecular targeted therapies
EGFR
Androgen insensitivity
Anti-PD1 blockade
COVID-19
Prevention
Advanced melanoma
Adverse events
TNM classification
Treatment
BRAF V600E
Lung cancer
Amgen
Chemoresistance
ACTH
Anti-PD-1 antibody
ALK
Polyomavirus
Metastatic cSCC
Anti-Tumor pharmacology
Resistance
Angiosarcoma
Colorectal carcinoma
Trametinib
Crizotinib
Antibody-drug conjugate
Anti-CTLA-4 anti-PD-1 elderly immune checkpoint inhibitors melanoma nonagenarian octogenarian
Immunohistochemistry
Biomarkers
Histiocytosis
Locally advanced
Colon cancer
AML
HIV
Immune checkpoint inhibitor
Staging
Dabrafenib
Systemic therapy
Liver metastases
Follow-up
Nivolumab
Adapted physical activity molecular diagnosis oligometastatic disease pancreatic adenocarcinoma KRAS mutation
Anti-CTLA-4
Adjuvant therapy
Biomarker
Adjuvant
Toxicity
Anti-PD-1
Circulating cell-free DNA
Chemotherapy
Cemiplimab
Prognostic
Metastatic
Abdominal pain
Adjuvant FOLFOX
Immunotherapy
Radiofrequency ablation
BRAF
ALK rearrangement
Safety
Advanced
Abscopal effect
Invasive cutaneous squamous cell carcinoma
ADAMTS13
Cancer
2-chlorodeoxyadenosine
Diagnosis
Osimertinib
Lung adenocarcinoma
Merkel cell carcinoma
Cancer bronchique non à petites cellules
Sonic Hedgehog